The incidence and prevention of symptomatic thromboembolic disease following unicompartmental knee arthroplasty

Orthopedics

Volumn 30, Issue 5 SUPPL., 2007, Pages 46-48

  Lombardi Jr , Adolph V ^a,b   Berend, Keith R ^a,b   Tucker, Tawnya L ^a  

^a Joint Implant Surgeons Inc   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTHROSCOPY; ARTICLE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; INCIDENCE; KNEE ARTHROPLASTY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MINIMALLY INVASIVE SURGERY; RADIODIAGNOSIS; RISK ASSESSMENT; SURGEON; SURGICAL PATIENT; SURGICAL TECHNIQUE; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, KNEE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; MIDDLE AGED; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK ASSESSMENT; VENOUS THROMBOSIS;

EID: 34249862145     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Murray DW, Goodfellow JW, O'Connor JJ. The Oxford medial unicompartmental arthroplasty: a ten-year survival study. J Bone Joint Surg Br. 1998; 80:983-989.
2. Price AJ, Waite JC, Svard U. Long-term clinical results of the medial Oxford unicompartmental knee arthroplasty. Clin Orthop Relat Res. 2005; 435:171-180.
3. Svard UC, Price AJ. Oxford medial unicompartmental knee arthroplasty. A survival analysis of an independent series. J Bone Joint Surg Br. 2001; 83:191-194.
4. Vorlat P, Putzeys G, Cottenie D, et al. The Oxford unicompartmental knee prosthesis: an independent 10-year survival analysis. Knee Surg Sports Traumatol Arthrosc. 2006; 14:40-45.
5. Keblish PA, Baird JL. Mobile-bearing unicompartmental knee arthroplasty: a 2-center study with an 11-year follow-up. J Arthroplasty. 2004; 19(suppl 2):87-94.
6. Price AJ, Webb J, Topf H, et al. Rapid recovery after Oxford unicompartmental arthroplasty through a small incision. J Arthroplasty. 2001; 16:970-976.
7. Beard DJ, Murray DW, Rees JL, Price AJ, Dodd CA. Accelerated recovery for unicompartmental knee replacement - a feasibility study. Knee. 2002; 9:221-224.
8. Warwick DJ, Whitehouse S. Symptomatic venous thromboembolism after total knee replacement. J Bone Joint Surg Br. 1997; 79:780-786.
9. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br. 1995; 77:6-10.
10. Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH. meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am. 2000; 82:929-938.
11. Lotke PA. DVT prophylaxis options: facts and fictions. Orthopedics. 1998; 21:1025-1026.
12. Berend KP, Lombardi AV Jr. Multimodal vencus thromboembolic disease Prevention for patients undergoing primary or revision total joint arthroplasty: the role of aspirin. Am J Orthop. 2006; 35:24-29.
13. Anon. Letter to editor: Prevention of pulmonary embolism and deep venous thrombosis with low dose aspirin. Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000; 355:1295-1302.
14. Sarmiento A, Goswami AD. Thromboembolic prophylaxis with use of aspirin, exercise, and graded elastic stockings or intermittent compression devices in patients managed with total hip arthroplasty. J Bone Joint Surg Am. 1999; 81:339-346.
15. Lotke PA. The role of aspirin for thromboembolic disease in total joint arthroplasty. Am J Knee Surg. 1999;12:61-63.
16. Lotke PA, Palevsky H, Keenan AM, et al. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop Relat Res. 1996; 324:251-258.
17. Rodgers A. Low-dose aspirin prevented deep venous thrombosis and pulmonary embolism after surgery for hip fracture. J Bone Joint Surg Am. 2000; 82:1807.
18. Woolson ST. Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement. J Bone Joint Surg Am. 1996; 78:1735-1740.
19. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology. 2003; 99:552-560.
20. Brookenthal KR, Freedman KB, Lotke PA, Fitzgerald RH, Lonner JH. A meta-analysis of thromboembolic prophylaxis in total knee arthroplasty. J Arthroplasty. 2001;16:293-300.
21. Woolson ST, Robinson RY, Khan NQ, Roqers BS, Maloney WJ. Deep venous thrombosis prophylaxis for knee replacement: warfarin and pneumatic compression. Am J Orthop. 1998; 7:299-304.
22. Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med. 2001; 345:1305-1310.
23. Lassen MR, Bauer KA, Eriksson BI, Turpie AG; European Pentasaccharide Elective Surgery Study (EPHESUS) Swering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism. in elective hi-replacement surgery: a randomized double-blinded comparison. Lancet. 2002; 359:1715-1720.
24. Turpie AG, Bauer KA, Enksson BI, Lassen MR; PENTATHALON 2000 Study Steering Committee. Postoperative fondaparinux postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: an randomized double-blind trial. Lancet. 2002; 359:1721-1726.